Clinical Trial Results:
A Multicenter, Randomized, Double-blind, Active-Controlled Study of the Efficacy and Safety of Flexibly-Dosed BMS-820836 in Patients with Treatment Resistant Major Depression
Revised protocol 03(dated 15-Oct-2012) incorporating Protocol Amdt 02
(dated 18-Apr-2011), Protocol Amdt 03 (dated 09-Nov-2011), Protocol Amdt 04 (dated 15-Oct-2012)
+ Pharmacogenetic amendment 01 (dated 30-Nov-2010)
Summary
|
|
EudraCT number |
2010-022841-93 |
Trial protocol |
SE FI |
Global completion date |
28 Jan 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
08 Dec 2016
|
First version publication date |
08 Dec 2016
|
Other versions |
|
Summary report(s) |
CN162-006_Synopses |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.